Brewers pitcher Ever Urena suspended 56 games for drug test
- Ever Urena, a minor league pitcher for the Milwaukee Brewers, has been suspended for 56 games after testing positive for Stanozolol.
- He had a successful start in the Dominican Summer League, recording a 0.00 ERA and one save in six games.
- This suspension is part of a larger trend, with 15 players suspended this year for drug violations, emphasizing the ongoing battle against performance-enhancing drugs in baseball.
Ever Urena, a 19-year-old right-handed pitcher for the Milwaukee Brewers' minor league team, has been handed a 56-game suspension due to a positive test for Stanozolol, a performance-enhancing substance. This suspension falls under the drug program specifically designed for players assigned outside the United States and Canada. Urena had recently signed a minor league contract with the Brewers in July and had shown promising performance in the Dominican Summer League, boasting a 0.00 ERA and one save over six games and 5 1/3 innings. The suspension is part of a broader issue within baseball, as 15 players have faced suspensions this year for similar violations. Among these, seven players were suspended under the new program for minor league players assigned outside the U.S. and Canada, while six were under the traditional minor league program. This indicates a growing concern regarding the use of performance-enhancing drugs in baseball, particularly among younger and less established players. The implications of Urena's suspension extend beyond his personal career, as it highlights the ongoing efforts by Major League Baseball to enforce strict drug policies. The league aims to maintain the integrity of the sport and ensure a level playing field for all athletes. Urena's case serves as a reminder of the potential consequences athletes face when they engage in doping practices. As the season progresses, the Brewers will need to adjust their roster in light of Urena's absence. This situation may also prompt discussions within the organization about the importance of education regarding drug use and the potential risks associated with performance-enhancing substances.